EPISODE · Apr 23, 2020 · 21 MIN
Aussie Start-Ups on the Commercialisation Runway – Meet Tournicare & Navi Medical Technologies
from The MTPConnect Podcast · host MTPConnect
Happy Thursday subscribers! This week’s edition features the Founders of two emerging Australian medtech start-ups, Tournicare's Co-Founder & CEO Niels van Sparrentak & Navi Medical Technologies’ Co-Founder & Co-CFO Brad Bergmann, who were selected as a Winner and a Finalist, respectively, in the 2019 Australian Technology Competition. Tournicare have designed a unique home blood pressure monitoring device that patients with hypertension can apply to the arm using only one hand. Navi Medical Technologies have developed ‘neoNav’, a medtech device that is an electrocardiogram (ECG) tip location system that helps medical staff more accurately place catheters in the veins of critically unwell babies. The Competition, in its 10th year, is supported by MTPConnect and provides a platform for companies of all sectors to access industry connections, partnership opportunities, seed investment and strategic advice. Host Shannan Osrin catches up with Niels and Brad to find out how the Competition has helped to commercialise their important medical devices, their tips on start-up success and how they are operating in this COVID-19 climate.
What this episode covers
Happy Thursday subscribers! This week’s edition features the Founders of two emerging Australian medtech start-ups, Tournicare's Co-Founder & CEO Niels van Sparrentak & Navi Medical Technologies’ Co-Founder & Co-CFO Brad Bergmann, who were selected as a Winner and a Finalist, respectively, in the 2019 Australian Technology Competition. Tournicare have designed a unique home blood pressure monitoring device that patients with hypertension can apply to the arm using only one hand. N...
NOW PLAYING
Aussie Start-Ups on the Commercialisation Runway – Meet Tournicare & Navi Medical Technologies
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m